Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations.
Saved in:
| Title: | Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations. |
|---|---|
| Authors: | Small AM; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Cardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital, Boston.; Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Pournamdari A; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California.; Department of Biomedical Data Science, Stanford University, Stanford, California., Melloni GEM; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Scirica BM; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Bhatt DL; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York., Raz I; Department of Endocrinology and Metabolism, Hadassah Hebrew University Hospital, Jerusalem, Israel., Braunwald E; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Giugliano RP; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Sabatine MS; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Peloso GM; Department of Biostatistics, Boston University School of Public Health, Boston University, Boston, Massachusetts., Marston NA; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Natarajan P; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Cardiovascular Research Center and Center for Genomic Medicine, Massachusetts General Hospital, Boston.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Associate Editor, JAMA Cardiology. |
| Source: | JAMA cardiology [JAMA Cardiol] 2024 Apr 01; Vol. 9 (4), pp. 385-391. |
| Publication Type: | Randomized Controlled Trial; Journal Article |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101676033 Publication Model: Print Cited Medium: Internet ISSN: 2380-6591 (Electronic) NLM ISO Abbreviation: JAMA Cardiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
